What is new in kidney cancer?

Kirkali Z.

Expert Review of Anticancer Therapy, cilt.9, sa.12, ss.1753-1755, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 9 Sayı: 12
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1586/era.09.154
  • Dergi Adı: Expert Review of Anticancer Therapy
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1753-1755
  • Anahtar Kelimeler: Metastatic, Renal cell carcinoma, Tyrosine kinase inhibitor
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Renal cell carcinoma is a hot topic in urologic oncology, thanks to a better understanding of the disease mechanisms, which has resulted in the developments and approval of targeted therapies. Six agents are now approved in the treatment of metastatic renal cell carcinoma. Some new information was presented at the recent Joint 15th European Cancer Organisation (ECCO) - 34th European Society of Medical Oncology (ESMO) Multidisciplinary Congress in Berlin. This article highlights the most important presentations at this meeting. © 2009 Expert Reviews Ltd.